p53 autoantibodies in sera of patients with a colorectal cancer and their association to p53 protein concentration and p53 immunohistochemistry in tumor tissue
Autor: | H.-P. Bruch, Rainer Broll, Oliver Schwandner, U. Windhövel, M. Duchrow, Elisabeth Oevermann, H. Schimmelpenning, C. Wellm, Uwe J. Roblick |
---|---|
Rok vydání: | 2001 |
Předmět: |
Adult
Male Pathology medicine.medical_specialty Colorectal cancer Enzyme-Linked Immunosorbent Assay Tumor M2-PK Adenocarcinoma Sensitivity and Specificity Reference Values Biomarkers Tumor Carcinoma medicine Humans Prospective Studies Survival analysis Aged Autoantibodies Probability Tumor marker Aged 80 and over business.industry Gastroenterology Autoantibody Middle Aged Prognosis medicine.disease Immunohistochemistry Survival Analysis Female Tumor Suppressor Protein p53 Colorectal Neoplasms business Immunostaining |
Zdroj: | International Journal of Colorectal Disease. 16:22-27 |
ISSN: | 1432-1262 0179-1958 |
DOI: | 10.1007/s003840000263 |
Popis: | We evaluated p53 autoantibodies (p53-Ab) as a preoperative tumor marker and as a prognosis marker. We also investigated whether p53-Ab production is dependent on p53 protein overexpression in tumor tissue or on tumor volume. Serum samples of patients with a colorectal cancer (n = 130) and of healthy controls (n = 44) were examined for p53-Ab using an ELISA kit. P53 protein expression in tumor tissue was demonstrated immunohistochemically and quantified by ELISA. Tumor volume was calculated and patients' survival computed using the Kaplan-Meier method. p53-Ab were detected in the serum from 15% of patients; all controls were negative. There was a significant correlation between p53-Ab production and positive immunostaining or p53 protein concentration in tumor tissue. p53-Ab were detected at a higher percentage of patients with a tumor volume of 10 cm3 or greater than in those with a smaller tumor. No difference in patients' prognosis was found between the p53-Ab positive and negative groups. Because of their low sensitivity (15%) p53-Ab are not suitable as a preoperative tumor marker. However, their high specificity (100%) and their potential for early diagnosis of a tumor relapse makes them valuable for postoperative monitoring during follow-up in p53-Ab positive patients. Furthermore, their detection can be used as a simple serological test for early detection of p53 alterations. |
Databáze: | OpenAIRE |
Externí odkaz: |